Planned trial:
- Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for Patients with Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sézary Syndrome
HTLV guideline from Chile
Access the guideline from the URL provided below:...
Planned Trial: rhIL-15 & Mogamulizumab
Other guidelines and trials you may be interested in…
read more
HTLV guideline from Brazil
Access the guideline from the URL provided below:...
International Health Policy Forum for the Elimination of HTLV: Advancing HTLV Health Policies around the World
Human T cell lymphotropic virus (HTLV) infection affects mainly vulnerable population groups: people living in poverty...